Wesana Health Holdings Inc.
WESAX
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -72.25% | -29.37% | -66.49% | -72.33% | -68.41% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -72.25% | -29.37% | -67.50% | -72.79% | -68.80% |
| Operating Income | 72.25% | 29.37% | 67.46% | 72.78% | 68.81% |
| Income Before Tax | 80.63% | -59.37% | 4.09% | 46.53% | -0.14% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 80.63% | -59.37% | 4.09% | 46.53% | -0.14% |
| Earnings from Discontinued Operations | -188.77% | 172.81% | 122.04% | 106.32% | 102.46% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 49.49% | 67.32% | 70.93% | 79.97% | 92.31% |
| EBIT | 72.25% | 29.37% | 67.46% | 72.78% | 68.81% |
| EBITDA | -- | -- | -- | -- | 86.69% |
| EPS Basic | 49.62% | 67.34% | 71.55% | 80.73% | 89.59% |
| Normalized Basic EPS | 100.29% | 88.64% | 88.14% | 86.68% | 38.08% |
| EPS Diluted | 49.62% | 67.34% | 71.55% | 80.73% | 89.59% |
| Normalized Diluted EPS | 100.29% | 88.64% | 88.14% | 86.68% | 38.08% |
| Average Basic Shares Outstanding | 0.05% | 0.12% | 0.95% | 2.22% | -10.71% |
| Average Diluted Shares Outstanding | 0.05% | 0.12% | 0.95% | 2.22% | -10.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |